111 related articles for article (PubMed ID: 21804519)
1. Sezary syndrome.
Ali CM; Sikdar TK; Sultana N; Hoque MR; Ahmed N; Parvez Z; Kamal B; Rahman F
Mymensingh Med J; 2011 Jul; 20(3):497-500. PubMed ID: 21804519
[TBL] [Abstract][Full Text] [Related]
2. Sezary syndrome presenting with leonine facies and treated with low-dose subcutaneous alemtuzumab.
Oliveira A; Lobo I; Alves R; Lima M; Selores M
Dermatol Online J; 2011 Nov; 17(11):6. PubMed ID: 22136862
[TBL] [Abstract][Full Text] [Related]
3. A case of pre-Sézary syndrome preceded by hand lesions.
Lee NH; Lee SW; Choi EH; Lee WS; Ahn SK
J Dermatol; 1999 Jul; 26(7):465-8. PubMed ID: 10458089
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma.
Akpek G; Koh HK; Bogen S; O'Hara C; Foss FM
Cancer; 1999 Oct; 86(7):1368-76. PubMed ID: 10506727
[TBL] [Abstract][Full Text] [Related]
5. [The Sézary syndrome].
Ferreira F; Correia TM; Callabro L; Andrade J
Acta Med Port; 1998 Dec; 11(12):1135-9. PubMed ID: 10192992
[TBL] [Abstract][Full Text] [Related]
6. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM
Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256
[TBL] [Abstract][Full Text] [Related]
7. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.
Cunningham D; Hawkes EA; Jack A; Qian W; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford JA; McMillan A; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D
Lancet; 2013 May; 381(9880):1817-26. PubMed ID: 23615461
[TBL] [Abstract][Full Text] [Related]
8. [22-year-old man with T-cell-lymphoma and new skin lesions].
Kampfenkel T; Schroers R; Kreuter A
Dtsch Med Wochenschr; 2012 Mar; 137(9):429-30. PubMed ID: 22354798
[No Abstract] [Full Text] [Related]
9. [Sézary syndrome (author's transl)].
Konrads A; Laaser U; Mödder B; Hummerich W; Lang R; Meurer KA; Zach J; Steinbrich W; Krueger GR; Schaefer HE
Dtsch Med Wochenschr; 1980 Mar; 105(11):378-83. PubMed ID: 7363776
[TBL] [Abstract][Full Text] [Related]
10. [Clinico-hematological effect of spirobromin in chronic lympholeukemia amd malignant non-Hodgkin's lymphoma].
Polianskaia AM; Khrennikova GIu; Sevast'ianova MG; Naumova GA
Gematol Transfuziol; 1987 Aug; 32(8):19-20. PubMed ID: 3678800
[No Abstract] [Full Text] [Related]
11. A randomized comparative study of cyclophosphamide, vincristine, doxorubicin, and prednisolone and cyclophosphamide, vincristine, mitoxantrone, and prednisolone regimens in the treatment of intermediate- and high-grade lymphoma with 8 years' follow-up.
Bezwoda WR; Rastogi RB
Semin Hematol; 1994 Apr; 31(2 Suppl 3):3. PubMed ID: 8073304
[No Abstract] [Full Text] [Related]
12. Reduced neurotoxicity with combined treatment of high-dose methotrexate, cyclophosphamide, doxorubicin, vincristine and prednisolone (M-CHOP) and deferred radiotherapy for primary central nervous system lymphoma.
Ichikawa T; Kurozumi K; Michiue H; Ishida J; Maeda Y; Kondo E; Kawasaki A; Date I
Clin Neurol Neurosurg; 2014 Dec; 127():106-11. PubMed ID: 25459253
[TBL] [Abstract][Full Text] [Related]
13. Exceptionally long disease-free period in a case of Sézary syndrome after combined treatment with leukapheresis and chemotherapy.
Di Guglielmo R; Miliani A; Avanzi G; Cozzolino F; Duminuco M; Vannucci R; Occhini U
Haematologica; 1987; 72(6):541-3. PubMed ID: 3126113
[No Abstract] [Full Text] [Related]
14. Successful treatment of chemotherapy-refractory Sézary syndrome with alemtuzumab (Campath-1H).
Gautschi O; Blumenthal N; Streit M; Solenthaler M; Hunziker T; Zenhäusern R
Eur J Haematol; 2004 Jan; 72(1):61-3. PubMed ID: 14962265
[TBL] [Abstract][Full Text] [Related]
15. [Lymphomatoid granulomatosis treated with oral cyclophosphamide and prednisolone followed by CHOP].
Kure T; Uozumi K; Kikuchi A; Owatari S; Tsuji T; Haraguchi K; Tokunaga M; Tokunaga M; Suzuki S; Arima T
Nihon Naika Gakkai Zasshi; 2004 Apr; 93(4):774-6. PubMed ID: 15174726
[No Abstract] [Full Text] [Related]
16. Pyoderma gangrenosum in a patient with primary cutaneous peripheral T-cell lymphoma, not otherwise specified.
Patsatsi A; Koletsa T; Sotiriadis D; Kartsios C; Papaconstantinou A; Kostopoulos I
Eur J Dermatol; 2012; 22(6):792-3. PubMed ID: 23228951
[No Abstract] [Full Text] [Related]
17. [Malignant lymphoma of the skin].
Nakajima H; Miyamoto H
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1735-43. PubMed ID: 3876074
[TBL] [Abstract][Full Text] [Related]
18. [Primary subcutaneous mantle cell lymphoma treated successfully with THP-COP therapy].
Hisatake J; Kawakami K; Nakamaki T; Hino K; Tomoyasu S
Rinsho Ketsueki; 2002 May; 43(5):384-8. PubMed ID: 12096492
[TBL] [Abstract][Full Text] [Related]
19. [Follicular lymphoma in two brothers].
Asahi A; Okamoto S; Matsushita H; Hattori Y; Takayama N; Ikeda Y
Rinsho Ketsueki; 2001 May; 42(5):408-13. PubMed ID: 11452461
[TBL] [Abstract][Full Text] [Related]
20. [T cell lymphoma successfully treated with multiple chemotherapy including DTIC].
Shimizu T; Kosumi N; Takeshima M; Yanagawa S; Mizoguchi M
Nihon Hifuka Gakkai Zasshi; 1983 Aug; 93(9):935-42. PubMed ID: 6607373
[No Abstract] [Full Text] [Related]
[Next] [New Search]
